{"id":344173,"date":"2026-11-11T17:26:58","date_gmt":"2026-11-11T11:56:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/bafna-pharmaceuticals-q2-results-fy27-pat-7-crore\/"},"modified":"2026-11-11T17:26:58","modified_gmt":"2026-11-11T11:56:58","slug":"bafna-pharmaceuticals-q2-results-fy27-pat-7-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/bafna-pharmaceuticals-q2-results-fy27-pat-7-crore\/","title":{"rendered":"Bafna Pharmaceuticals Q2 Results FY27: PAT Jumps 119.55% to Rs 6.85 Cr, Revenue Rs 47.67 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Bafna Pharmaceuticals Q2 Results FY27 were declared on 11 November 2026 on a Standalone basis. Revenue for the July to September 2026 quarter rose 34.40% YoY to Rs 47.67 Cr from Rs 35.47 Cr. Net profit climbed 119.55% YoY to Rs 6.85 Cr from Rs 3.12 Cr. These quarterly results show strong YoY growth in both sales and profit.<\/p>\n<\/div>\n

Bafna Pharmaceuticals Ltd<\/a> (BAFNAPH) Q2 Results FY27 announced on 11 November 2026, covering the company’s financial performance for the July to September quarter. The results date brought Standalone figures with revenue of Rs 47.67 Cr and PAT of Rs 6.85 Cr. Bafna Pharmaceuticals Q2 Results FY27 show revenue 34.40% higher than last year, with net profit up 119.55% YoY, as the standalone results below confirm.<\/p>\n

This results analysis covers the financial highlights, the business drivers, the outlook and the risks for the quarter. Readers who follow Bafna Pharmaceuticals Q2 Results on Univest can start with the summary table that comes next, and then move into the detailed reading.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n